Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Daily Cost of Wyeth’s Pristiq For Depression Beats Effexor By 20 Percent

This article was originally published in The Pink Sheet Daily

Executive Summary

50 mg and 100 mg Pristiq tablets will be sold for a flat rate of $3.41, firm announces during an April 22 first quarter sales and earnings call.

You may also be interested in...

FDA Clears Wyeth’s Pristiq For Depression

New study in menopausal hot flashes and night sweats is due first half of this year.

FDA Extends Wyeth, Progenics NDA Review For Methylnaltrexone Until April

Additional three months of review will push methylnaltrexone action date behind GSK/Adolor’s Entereg.

IFRA Hosts Capitol Hill Scent Experience In Timeout From Policy Concerns

The International Fragrance Association North America took a break from its higher-stakes advocacy work Nov. 1 to give lawmakers and congressional staffers a "scent experience." Perfumers from six of the group's biggest members were on hand with "Scents of Home," joined by Monell Center researchers to educate attendees on the mechanics of scent and the important role it plays in people's lives.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts